Australia markets close in 3 hours 44 minutes

Sonnet BioTherapeutics Holdings, Inc. (SONN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.7600-0.0500 (-2.76%)
At close: 04:00PM EDT
1.8000 +0.04 (+2.27%)
After hours: 06:29PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.40M
Enterprise value 2.57M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)26.01
Price/book (mrq)2.10
Enterprise value/revenue 19.88
Enterprise value/EBITDA -0.18

Trading information

Stock price history

Beta (5Y monthly) 1.12
52-week change 3-66.67%
S&P500 52-week change 321.08%
52-week high 326.4000
52-week low 31.0800
50-day moving average 31.8822
200-day moving average 32.9776

Share statistics

Avg vol (3-month) 3103.76k
Avg vol (10-day) 319.09k
Shares outstanding 53.07M
Implied shares outstanding 63.22M
Float 82.71M
% held by insiders 19.22%
% held by institutions 13.53%
Shares short (15 Apr 2024) 4424.16k
Short ratio (15 Apr 2024) 47.85
Short % of float (15 Apr 2024) 414.22%
Short % of shares outstanding (15 Apr 2024) 413.82%
Shares short (prior month 15 Mar 2024) 4557.46k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 302 Apr 2020
Ex-dividend date 4N/A
Last split factor 21:22
Last split date 301 Sept 2023

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-6,866.05%

Management effectiveness

Return on assets (ttm)-175.81%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)129.18k
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)-50.00%
Gross profit (ttm)N/A
EBITDA -14.45M
Net income avi to common (ttm)-14.46M
Diluted EPS (ttm)-0.7900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.02M
Total cash per share (mrq)0.98
Total debt (mrq)186.69k
Total debt/equity (mrq)7.26%
Current ratio (mrq)1.74
Book value per share (mrq)0.84

Cash flow statement

Operating cash flow (ttm)-18.52M
Levered free cash flow (ttm)-13.56M